ECG Event Recorder Market Analysis

  • Report ID: 3801
  • Published Date: Sep 25, 2025
  • Report Format: PDF, PPT

ECG Event Recorder Market Segmentation:

Device Type Segment Analysis

Wearable ECG recorders are poised to lead the sector with a share of 46.6% by the end of 2035. The leadership in this sector is largely fueled by the increasing surge in remote and real-time cardiac monitoring, particularly among older adults. These devices provide convenience while spotting heart issues at an early stage, fostering a greater acceptance than other solutions available in the market. Besides, wearables have been clinically proven to be a cost-effective solution for patients seeking affordable options. The substantial demand base in this segment can be further testified by the NLM findings, stating that a total of 280 million units of smartwatches and fitness trackers were shipped worldwide in 2024, showcasing an 11% rise from 2021.

Monitor Type Segment Analysis

Symptom event monitors are expected to garner a majority of the net revenue generation in the ECG event recorder market over the analyzed period. Due to having the ability to identify episodes of symptoms even through subtle recordings, this subtype is highly desired across various medical settings. This type of devices enable crucial insights for diagnosing asymptomatic cardiac arrhythmias, making them one of the most used tools in outpatient environments that require cost-effective and user-friendly solutions. Moreover, prioritization of quick and on-site diagnosis in preventing serious complications solidifies the segment’s forefront position in this sector.

Application Segment Analysis

Cardiac arrhythmia monitoring is predicted to remain the dominant application segment in the ECG event recorder market throughout the discussed timeline. Amplifying patient volume of this medical condition is the primary growth factor in this category. As evidence, the Global Burden of Disease (GBD) data underscored that the number of new cases, DALYs, and deaths of AFib around the world accounted for 4.4 million, 8.3 million, and 340,000, respectively, in 2021. In the same year, another NLM study estimated the absolute volume of this condition globally to rise by more than 60% in 2050. These figures, coupled with the rapidly aging populations, indicate continuous expansion of this segment in the future.

Our in-depth analysis of the market includes the following segments:

Segment

      Subsegment

Device Type

  • Wearable ECG Recorders
  • Single-Lead Wearables
  • 3-Lead Wearables
  • Portable ECG Recorders
  • 6-Lead Portables
  • 12-Lead Portables
  • 3-Lead Portables
  • Implantable Loop Recorders
  • Single-Lead Implantables

Monitor Type

  • Symptom Event Monitors
  • Arrhythmia Detection
  • Post-Op Monitoring
  • Home-Based Monitoring
  • Loop Memory Monitors
  • Chronic Arrhythmia Tracking
  • Remote Post-Op Monitoring
  • Emergency Rhythm Capture
  • Real-Time Event Monitors
  • Live Cardiac Monitoring
  • Emergency Arrhythmia Alerts
  • Continuous Remote Monitoring

Lead Type

  • 12-Lead ECG Devices
  • 6-Lead ECG Devices
  • 3-Lead ECG Devices
  • Single-Lead ECG Devices

Technology

  • AI-Integrated ECG Systems
  • Cloud-Based ECG Monitoring
  • Wireless ECG Devices
  • Traditional ECG Systems

Application

  • Cardiac Arrhythmia Monitoring
  • Post-Operative Care
  • Remote Patient Monitoring
  • Emergency Response Services

Distribution Channel

  • Online Stores
  • Pharmacies
  • Specialty Stores
  • Others

End user

  • Hospitals
  • Clinics & Cardiac Centers
  • Ambulatory Surgical Centers
  • Home Healthcare Settings
  • Others

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2026, the industry size of ECG event recorder is assessed at USD 1.8 billion.

ECG Event Recorder Market size was over USD 1.7 billion in 2025 and is estimated to reach USD 3.4 billion by the end of 2035, expanding at a CAGR of 8.1% during the forecast timeline, i.e., 2026-2035.

North America industry is predicted to account for the largest share of 39.3% by 2035, owing to a well-developed cardiac care infrastructure in the region.

The major players in the market are Koninklijke Philips N.V., WellDoc, Inc., Noom, Inc., Pear Therapeutics, Inc., Teladoc Health, Inc., Click Therapeutics, Inc., Ayogo Health Inc., Mindstrong Health, and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos